发育性髋关节发育不良支具治疗中的股神经麻痹:前瞻性国际队列的发生率与结局
本研究基于全球多中心前瞻性数据库,纳入3008例(5012髋)以矫形器为主要治疗的发育性髋关节发育不良(DDH)患儿,分析股神经麻痹的危险因素。结果显示94例(3.1%)患儿99髋(2.0%)发生股神经麻痹,中位发生时间为支具应用后7天;Pavlik吊带使用比例在发生股神经麻痹的患儿中显著更高,股骨头覆盖百分比低和α角小是独立危险因素。
要点
- DDH支具治疗中股神经麻痹发生率为3.1%(患儿)和2.0%(髋),中位发生时间7天。
- Pavlik吊带使用与股神经麻痹发生显著相关(84.0% vs 61.9%,p<0.001)。
- 股骨头覆盖百分比低和α角小是股神经麻痹的独立危险因素。
核心结论
- DDH支具治疗中股神经麻痹发生率为3.1%,DDH严重程度(股骨头覆盖低、α角小)是显著危险因素。
- 使用Pavlik吊带与股神经麻痹发生显著相关。
研究设计与样本
- 全球多中心前瞻性数据库分析,纳入21个中心、7个国家的3008例(5012髋)以矫形器为主要治疗的DDH患儿。
- 采用混合效应逻辑回归进行单变量和多变量分析,评估性别、诊断及支具应用时年龄、支具类型、股骨头位置、股骨头覆盖和α角等危险因素。
主要发现
- 94例(3.1%)患儿、99髋(2.0%)发生股神经麻痹,中位发生时间为支具应用后7天(IQR 6-21)。
- 发生股神经麻痹的患儿中Pavlik吊带使用比例为84.0%(n=79),未发生者为61.9%(n=1804),差异显著(p<0.001)。
- 单变量分析显示股骨头覆盖百分比较低(OR 0.87,95%CI 0.84-0.91,p<0.001)和α角较低(OR 0.82,95%CI 0.76-0.89,p<0.001)与股神经麻痹发生显著相关,多变量模型中仍显著。
关键数值与推荐
- 股神经麻痹发生率:患儿3.1%(94/3008),髋2.0%(99/5012)。
- 股骨头覆盖百分比OR 0.87(95%CI 0.84-0.91),p<0.001;α角OR 0.82(95%CI 0.76-0.89),p<0.001。
临床怎么用
- 对DDH支具治疗患儿,尤其使用Pavlik吊带、股骨头覆盖低或α角小者,应警惕股神经麻痹,注意早期(约7天内)监测。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Femoral nerve palsy is a potential complication of brace treatment for children with developmental dysplasia of the hip (DDH). Little is known about its causes, and previous studies have been limited by their small sample size, retrospective design, and/or being single-centre series. The aim of this study was to examine the risk factors for femoral nerve palsy in the largest prospective cohort of children to date with DDH treated using an orthosis. METHODS: A global multicentre prospective database of children with DDH was analyzed. Those treated primarily using an orthosis were included. Mixed-effects logistic regression was used to identify risk factors for the development of femoral nerve palsy, including sex, age at the time of diagnosis and application of an orthosis, the type of orthosis, the location of the femoral head, femoral head cover, and α angle. Both univariate and multivariate analyses were conducted. RESULTS: The study included 3,008 children (5,012 affected hips) who were enrolled from 21 centres in seven countries; 99 hips (2.0%) in 94 children (3.1%) developed a femoral nerve palsy, which occurred at a median of seven days (IQR 6 to 21) after the application of a brace. A significantly increased proportion of children who developed a femoral nerve palsy were treated in a Pavlik harness compared with those who did not develop a femoral nerve palsy (84.0% (n = 79) vs 61.9% (n = 1,804); p < 0.001). Univariate analyses identified a lower percent cover of the femoral head (odds ratio (OR) 0.87 (95% CI 0.84 to 0.91); p < 0.001) and lower α angle (OR 0.82 (95% CI 0.76 to 0.89); p < 0.001) to be significantly associated with the development of femoral nerve palsy. These risk factors remained significant in the multivariate model. CONCLUSION: This is the largest multinational study to date evaluating the incidence and risk factors for the development of a femoral nerve palsy in these children. The incidence of femoral nerve palsy was 3.1%. The severity of DDH was identified as a significant risk factor for its development. The use of a Pavlik harness was significantly associated with the development of a femoral nerve palsy. Understanding the factors which influence its development will be important to optimize outcomes of treatment in children with DDH.
引用
- Schaeffer EK, Wang AWT, Hu J, et al. Femoral nerve palsy in brace treatment for developmental dysplasia of the hip : incidence and outcomes in a prospective international cohort. Bone Joint J. 2026. PMID: 42219184. doi:10.1302/0301-620X.108B6.BJJ-2025-1550.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。